{"id":"W2787639107","doi":"10.1177/1758834017753338","title":"Turning <i>EGFR</i> mutation-positive non-small-cell lung cancer into a chronic disease: optimal sequential therapy with EGFR tyrosine kinase inhibitors","year":2018,"lang":"en","type":"review","venue":"Therapeutic Advances in Medical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Osimertinib; Afatinib; Erlotinib; T790M; Gefitinib; Medicine; Lung cancer; Tolerability; Oncology; Epidermal growth factor receptor; Resistance mutation; Erlotinib Hydrochloride; Tyrosine kinase; Internal medicine; Cancer research; Cancer; Adverse effect; Biology; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004114092,0.0002429827,0.0005025596,0.0001631614,0.0001738086,0.0007772097,0.0002794778,0.0003937116,0.0007779948],"category_scores_gemma":[0.0005290045,0.0001177685,0.000286987,0.0001161311,0.0002676979,0.0008291324,0.0004123446,0.001079114,0.0003279734],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003872505,"about_ca_system_score_gemma":0.0006786974,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003033844,"about_ca_topic_score_gemma":0.001424999,"domain_scores_codex":[0.9998403,0.00004492806,0.00002218689,0.00002068707,0.00003696813,0.00003492893],"domain_scores_gemma":[0.9998535,0.00003939934,0.00004035598,0.000005858401,0.00002017864,0.0000406919],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001665438,0.0006959683,0.00491534,0.00203071,0.0001398424,0.001597681,0.0002056837,0.002988934,0.04911826,0.008296377,0.01794818,0.9103976],"study_design_scores_gemma":[0.002000213,0.01834673,0.05220787,0.00431499,0.0009307414,0.03085732,0.001474028,0.02128947,0.05013701,0.03702007,0.7812153,0.0002062735],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2159303,0.6864761,0.03537372,0.026656,0.002459982,0.000303764,0.00015824,0.0003630891,0.03227882],"genre_scores_gemma":[0.6956035,0.2680036,0.02281003,0.004840821,0.003530102,0.0001864738,0.0002786558,0.00006036336,0.004686487],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0007779948,"threshold_uncertainty_score":0.002809703,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0187632283556493,"score_gpt":0.4154327985471971,"score_spread":0.3966695701915478,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}